← All companies

ABCL

AbCellera Biologics Inc.

ABCL Nasdaq Pharmaceutical Preparations EDGAR ↗

$5.83

+0.14 +2.46%

Key statistics

from XBRL data in SEC filings

Market cap

$1.78B

Revenue (TTM)

$79.2M

Net income (TTM)

-$144M

EPS (TTM)

$-0.48

P/E ratio

—

Dividend yield

—

Free cash flow

-$174M

Cash

$77.1M

Total assets

$1.31B

Gross margin

—

52-week range

$2.75 – $8.44

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 29, 2026 8-K Director or officer change Jul 6, 2026 8-K Other events Jun 17, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Director or officer change Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 8-K Regulation FD disclosure Jan 14, 2026 8-K Regulation FD disclosure Dec 18, 2025 8-K Changed accountants Nov 28, 2025 8-K Director or officer change Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 8-K Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Other events May 30, 2025 8-K Other events May 14, 2025 8-K Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 8-K Other events Feb 18, 2025 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 8-K Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2024 8-K Director or officer change Feb 23, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 20, 2024 8-K Other events Nov 28, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 2, 2023